Skip to main content

KROS

Keros Therapeutics, Inc.

Company with tickers: KROS

CIK
1664710
CUSIP
492327101
Shares Outstanding
19,791,837
13F Activity (30d)
13 filings 9 filers

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 149
Total Value: $201,004,528
Total Shares: 18,206,940
Showing 1–100 of 155 holdings by value · page 1 of 2

Institutional Ownership Trend

34 quarters

Holder Concentration

Across 149 13F filers · Δ vs Dec 31, 2025
Top Holder
13.2%
Jun 2025 → Mar 2026 · range 11.0% – 14.9%
+2.2 pts
Top 5
33.4%
Jun 2025 → Mar 2026 · range 33.4% – 43.5%
−0.5 pts
Top 10
51.5%
Jun 2025 → Mar 2026 · range 51.5% – 62.4%
−0.8 pts
HHI
419
Jun 2025 → Mar 2026 · range 395 – 545
Broadly held+23

Quarterly Activity

vs Dec 31, 2025
New
26
Increased
47
Decreased
55
Sold Out
42
Unchanged
21
Holder count: -16
Institutional value: -54.3%
Shares held: -15.8%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
Institution Sold Now Holds Open

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 100 of 155
Export CSV
Holder Value (USD) % of 13F Shares Open